Pembrolizumab: Role of Modeling and Simulation in Bringing a Novel Immunotherapy to Patients With Melanoma
Author:
Affiliation:
1. Merck & Co., Inc; Kenilworth New Jersey USA
2. Quantitative Solutions, a Certara company; Oss The Netherlands
3. PD-Value; Houten The Netherlands
Publisher
Wiley
Subject
Pharmacology (medical),Modelling and Simulation
Reference14 articles.
1. Evolving synergistic combinations of targeted immunotherapies to combat cancer;Melero;Nat. Rev. Cancer,2015
2. Immunotherapy in cancer: a combat between tumors and the immune system; you win some, you lose some;Madorsky Rowdo;Front. Immunol.,2015
3. The blockade of immune checkpoints in cancer immunotherapy;Pardoll;Nat. Rev. Cancer,2012
4. Cancer immunotherapy comes of age;Mellman;Nature,2011
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Designing Dose-Optimization Studies in Cancer Drug Development: Discussions with Regulators;Statistics in Biopharmaceutical Research;2023-02-14
2. Aiding early clinical drug development by elucidation of the relationship between tumor growth inhibition and survival in relapsed/refractory multiple myeloma patients;eJHaem;2022-06-02
3. The Role of Mathematical Models in Immuno-Oncology: Challenges and Future Perspectives;Pharmaceutics;2021-07-02
4. Mechanistic models for hematological toxicities: Small is beautiful;CPT: Pharmacometrics & Systems Pharmacology;2021-02-27
5. Dosage of anti-PD-1 monoclonal antibodies: a cardinal open question;Clinical and Translational Oncology;2021-02-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3